Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 94, Issue 2, 2008, Pages 165-171

  Momose, Yoshika ^a   Hirayama, Kazuhiro ^a   Itoh, Kikuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colonization resistance; Escherichia coli O157:H7; Gnotobiotic mice; Infant intestinal microbiota; Proline

Indexed keywords

AMINO ACID; PROLINE; RIFAMPICIN;

ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CECUM; CONTROLLED STUDY; CULTURE MEDIUM; ENTEROBACTERIACEAE; ESCHERICHIA COLI O157; FEMALE; GNOTOBIOTICS; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; INTESTINE FLORA; INTRASPECIFIC COMPETITION; MOUSE; NONHUMAN; NUTRIENT UPTAKE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACIDS; ANIMALS; ANTIBIOSIS; CATTLE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GERM-FREE LIFE; HUMANS; INFANT; INTESTINES; MICE; MICE, INBRED BALB C; PROLINE;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; MUS;

EID: 46749115557     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-008-9222-6     Document Type: Article

References (23)

1. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T (1989) Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol 55:1100-1105
2. Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986
3. Carman RJ, Simon MA, Fernández H, Miller MA, Bartholomew MJ (2004) Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats. Reg Toxicol Pharmacol 40:319-326
4. Donskey CJ, Hume ME, Callaway TR, Das SM, Hoyen CK, Rice LB (2001) Inhibition of vancomycin-resistant enterococci by an in vitro continuous-flow competitive exclusion culture containing human stool flora. J Infect Dis 184:1624-1627
5. Freter R, Brickner H, Botney M, Cleven D, Aranki A (1983) Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun 39:676-685
6. Gavini F, Cayuela C, Antoine JM, Lecoq C, Lefebvre B, Membre JM, Neut C (2001) Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microflora of three different (children, adults, elderly) age groups. Microbial Ecol Health Dis 13:40-45
7. Grainger DJ, Aitken S (2004) A microtitre format assay for proline in human serum or plasma. Clin Chim Acta 343:113-118
8. Guiot HFL (1982) Role of competition for substrate in bacterial antagonism in the gut. Infect Immun 38:887-892
9. Itoh M, Wada K, Tan S, Kitano Y, Kai J, Makino I (1999) Antibacterial action of bile acids against Helicobacter pylori and changes in its ultrastructural morphology: Effect of unconjugated dihydroxy bile acid. J Gastroenterol 34:571-576
10. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65:4506-4512
11. Mitsuoka T (2000) Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora 19:15-25
12. Momose Y, Hirayama K, Itoh K (2005) Antagonism of intestinal bacteria isolated from human infants against Escherichia coli O157:H7 infection in gnotobiotic mice. Microbial Ecol Health Dis 17:9-14
13. Momose Y, Hirayama K, Itoh K (2008) Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota. Antonie van Leeuwenhoek 93:141-149
14. Murinda SE, Roberts RF, Wilson RA (1996) Evaluation of colicins for inhibitory activity against diarrheagenic Escherichia coli strains, including serotype O157:H7. Appl Environ Microbiol 62:3196-3202
15. Pugsley AP, Oudega B (1987) Methods for studying colicins and their plasmids. In: HardA KG (ed) Plasmids: a practical approach. IRL Press, Oxford, pp 105-161
16. Que JU, Casey SW, Hentges DJ (1986) Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun 53:116-123
17. Reinders RD, Biesterveld S, Bijker PGH (2001) Survival of Escherichia coli O157:H7 ATCC 43895 in a model apple juice medium with different concentrations of proline and caffeic acid. Appl Environ Microbiol 67:2863-2866
18. Silva SH, Vieira EC, Dias RS, Nicoli JR (2001) Antagonism against Vibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota. J Med Microbiol 50:161-164
19. Snoeyenbos GH (1979) Role of native intestinal microflora in protection against pathogens. Proc Annu Meet US Anim Health Assoc 83:388-393
20. Toshima H, Hachio M, Ikemoto Y, Ogasawara J, Hase A, Takahashi K, Masaki H, Nishikawa Y (2007) Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans. Epidemiol Infect 135:110-117
21. Ushijima T, Seto A (1991) Selected faecal bacteria and nutrients essential for antagonism of Salmonella typhimurium in anaerobic continuous flow cultures. J Med Microbiol 35:111-117
22. Wilson KH, Perini F (1988) Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56:2610-2614
23. Yamamoto-Osaki T, Kamiya S, Sawamura S, Kai M, Ozawa A (1994) Growth inhibition of Clostridium difficile by intestinal flora of infant feces in continuous flow culture. J Med Microbiol 40:179-187